GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,158 | -51.1% | 13,762 | -29.1% | 0.00% | – |
| Q2 2023 | $106,722 | +133.1% | 19,404 | +82.2% | 0.00% | – |
| Q1 2023 | $45,782 | +454.7% | 10,647 | +407.0% | 0.00% | – |
| Q4 2022 | $8,253 | -31.2% | 2,100 | -5.3% | 0.00% | – |
| Q3 2022 | $12,000 | -33.3% | 2,218 | -17.1% | 0.00% | – |
| Q2 2022 | $18,000 | -60.0% | 2,674 | -56.2% | 0.00% | – |
| Q1 2022 | $45,000 | -68.5% | 6,106 | -69.6% | 0.00% | – |
| Q4 2021 | $143,000 | +741.2% | 20,113 | +2831.9% | 0.00% | – |
| Q3 2021 | $17,000 | +240.0% | 686 | +268.8% | 0.00% | – |
| Q2 2021 | $5,000 | -94.7% | 186 | -94.4% | 0.00% | – |
| Q1 2021 | $95,000 | -52.0% | 3,348 | -52.0% | 0.00% | – |
| Q4 2020 | $198,000 | -32.0% | 6,971 | -25.8% | 0.00% | – |
| Q3 2020 | $291,000 | – | 9,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |